Targeted metabolomic analysis of serum phospholipid and acylcarnitine in the adult Fontan patient with a dominant left ventricle
- PMID: 32426103
- PMCID: PMC7222265
- DOI: 10.1177/2040622320916031
Targeted metabolomic analysis of serum phospholipid and acylcarnitine in the adult Fontan patient with a dominant left ventricle
Abstract
Background: Patients with a Fontan circulation have altered cholesterol and lipoprotein values. We analysed small organic molecules in extended phopsholipid and acylcarnitine metabolic pathways ('metabolomes') in adult Fontan patients with a dominant left ventricle, seeking differences between profiles in baseline and Fontan circulations.
Methods: In an observational matched cross-sectional study, we compared phosphatidylcholine (PC), sphingomyelin (SM), and acylcarnitine metabolomes (105 analytes; AbsoluteIDQ® p180 kit (Biocrates Life Sciences AG, Innsbruck, Austria) in 20 adult Fontan patients having a dominant left ventricle with those in 20 age- and sex-matched healthy controls.
Results: Serum levels of total PC (q-value 0.01), total SM (q-value 0.0002) were significantly lower, and total acylcarnitines (q-value 0.02) were significantly higher in patients than in controls. After normalisation of data, serum levels of 12 PC and 1 SM Fontan patients were significantly lower (q-values <0.05), and concentrations of 3 acylcarnitines were significantly higher than those in controls (q-values <0.05).
Conclusion: Metabolomic profiling can use small specimens to identify biomarker patterns that track derangement in multiple metabolic pathways. The striking alterations in the phospholipid and acylcarnitine metabolome that we found in Fontan patients may reflect altered cell signalling and metabolism as found in heart failure in biventricular patients, chronic low-level inflammation, and alteration of functional or structural properties of lymphatic or blood vessels.
Trial registration number: ClinicalTrials.gov Identifier NCT03886935.
Keywords: Fontan; acylcarnitine; angiogenesis; congenital heart disease; heart failure; inflammation; lipid; lymphatic vessel; metabolism; metabolomics; phosphatidylcholine; phospholipid; sphingomyelin; vascular stiffening.
© The Author(s), 2020.
Conflict of interest statement
Conflict of interest statement: MM, KOD, MZ, DK, MGA, AE, MK, JK, IOK, RG, CS, CN, UM, SS-B, and KTL declare that they have no financial or non-financial competing interests with respect to the research, authorship, and/or publication of this article.
Figures



Similar articles
-
Targeted metabolomic analysis of serum amino acids in the adult Fontan patient with a dominant left ventricle.Sci Rep. 2020 Jun 2;10(1):8930. doi: 10.1038/s41598-020-65852-x. Sci Rep. 2020. PMID: 32488174 Free PMC article.
-
Targeted assessment of the metabolome in skeletal muscle and in serum of dairy cows supplemented with conjugated linoleic acid during early lactation.J Dairy Sci. 2021 Apr;104(4):5095-5109. doi: 10.3168/jds.2020-19185. Epub 2021 Mar 2. J Dairy Sci. 2021. PMID: 33663821
-
Serum Metabolite Biomarkers for Pancreatic Tumors: Neuroendocrine and Pancreatic Ductal Adenocarcinomas-A Preliminary Study.Cancers (Basel). 2023 Jun 19;15(12):3242. doi: 10.3390/cancers15123242. Cancers (Basel). 2023. PMID: 37370852 Free PMC article.
-
The Lymphatic System in the Fontan Patient-Pathophysiology, Imaging, and Interventions: What the Anesthesiologist Should Know.J Cardiothorac Vasc Anesth. 2022 Aug;36(8 Pt A):2669-2678. doi: 10.1053/j.jvca.2021.07.049. Epub 2021 Jul 31. J Cardiothorac Vasc Anesth. 2022. PMID: 34446325 Review.
-
Comparative Metabolomics in Single Ventricle Patients after Fontan Palliation: A Strong Case for a Targeted Metabolic Therapy.Metabolites. 2023 Aug 9;13(8):932. doi: 10.3390/metabo13080932. Metabolites. 2023. PMID: 37623876 Free PMC article. Review.
Cited by
-
Single-cell multiomics guided mechanistic understanding of Fontan-associated liver disease.Sci Transl Med. 2024 Apr 24;16(744):eadk6213. doi: 10.1126/scitranslmed.adk6213. Epub 2024 Apr 24. Sci Transl Med. 2024. PMID: 38657025 Free PMC article.
-
Comprehensive Multiomic Analysis Reveals Metabolic Reprogramming Underlying Human Fontan-Associated Liver Disease.J Am Heart Assoc. 2025 Mar 18;14(6):e039201. doi: 10.1161/JAHA.124.039201. Epub 2025 Mar 7. J Am Heart Assoc. 2025. PMID: 40055870 Free PMC article.
-
Metabolomics: A New Tool in Our Understanding of Congenital Heart Disease.Children (Basel). 2022 Nov 24;9(12):1803. doi: 10.3390/children9121803. Children (Basel). 2022. PMID: 36553246 Free PMC article. Review.
-
Potential Drug-Nutrient Interactions of 45 Vitamins, Minerals, Trace Elements, and Associated Dietary Compounds with Acetylsalicylic Acid and Warfarin-A Review of the Literature.Nutrients. 2024 Mar 26;16(7):950. doi: 10.3390/nu16070950. Nutrients. 2024. PMID: 38612984 Free PMC article. Review.
-
Metabolomics and random forests in patients with complex congenital heart disease.Front Cardiovasc Med. 2022 Oct 5;9:994068. doi: 10.3389/fcvm.2022.994068. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36277761 Free PMC article.
References
-
- Shaddy RE, Webb G. Applying heart failure guidelines to adult congenital heart disease patients. Expert Rev Cardiovasc Ther 2008; 6: 165–174. - PubMed
-
- Larsson DA, Meurling CJ, Holmqvist F, et al. The diagnostic and prognostic value of brain natriuretic peptides in adults with a systemic morphologically right ventricle or Fontan-type circulation. Int J Cardiol 2007; 114: 345–351. - PubMed
-
- Diller GP, Dimopoulos K, Okonko D, et al. Exercise intolerance in adult congenital heart disease: Comparative severity, correlates, and prognostic implication. Circulation 2005; 112: 828–835. - PubMed
-
- Giannakoulas G, Dimopoulos K, Bolger AP, et al. Usefulness of natriuretic peptide levels to predict mortality in adults with congenital heart disease. Am J Cardiol 2010; 105: 869–873. - PubMed
-
- Eindhoven JA, van den Bosch AE, Jansen PR, et al. The usefulness of brain natriuretic peptide in complex congenital heart disease: a systematic review. J Am Coll Cardiol 2012; 60: 2140–2149. - PubMed
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical